Cargando…
Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples
Quantitative Systems Toxicology (QST) models, recapitulating pharmacokinetics and mechanism of action together with the organic response at multiple levels of biological organization, can provide predictions on the magnitude of injury and recovery dynamics to support study design and decision-making...
Autores principales: | Pin, Carmen, Collins, Teresa, Gibbs, Megan, Kimko, Holly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137611/ https://www.ncbi.nlm.nih.gov/pubmed/34018069 http://dx.doi.org/10.1208/s12248-021-00580-2 |
Ejemplares similares
-
Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model
por: Nikfar, Mehdi, et al.
Publicado: (2023) -
Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021) -
Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model
por: Ruiz-Martinez, Alvaro, et al.
Publicado: (2022) -
Modeling the dynamic kinetics of microbial disinfection with dissipating chemical agents—a theoretical investigation
por: Peleg, Micha
Publicado: (2021) -
Assumption Checking Before Application of the Prespecified QT Linear Mixed Effect Model is Essential
por: Rekić, Dinko, et al.
Publicado: (2020)